Abstract
0120 SUVN-G3031, a Novel, Potent and Selective Histamine H3 Receptor Inverse Agonist for the Treatment of Narcolepsy: Preclinical Characterization
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have